[go: up one dir, main page]

NO950930D0 - Fremgangsmåte for å forsinke progresjon av koronararterie-atherosklerose ved anvendelse av pravastatin - Google Patents

Fremgangsmåte for å forsinke progresjon av koronararterie-atherosklerose ved anvendelse av pravastatin

Info

Publication number
NO950930D0
NO950930D0 NO950930A NO950930A NO950930D0 NO 950930 D0 NO950930 D0 NO 950930D0 NO 950930 A NO950930 A NO 950930A NO 950930 A NO950930 A NO 950930A NO 950930 D0 NO950930 D0 NO 950930D0
Authority
NO
Norway
Prior art keywords
pravastatin
coronary artery
delaying progression
artery atherosclerosis
atherosclerosis
Prior art date
Application number
NO950930A
Other languages
English (en)
Other versions
NO950930L (no
Inventor
Mark E Mcgovern
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO950930D0 publication Critical patent/NO950930D0/no
Publication of NO950930L publication Critical patent/NO950930L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO950930A 1994-03-11 1995-03-10 Fremgangsmåte for å forsinke progresjon av koronar-arterieatherosklerose ved anvendelse av pravastatin NO950930L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21247094A 1994-03-11 1994-03-11

Publications (2)

Publication Number Publication Date
NO950930D0 true NO950930D0 (no) 1995-03-10
NO950930L NO950930L (no) 1995-09-12

Family

ID=22791164

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950930A NO950930L (no) 1994-03-11 1995-03-10 Fremgangsmåte for å forsinke progresjon av koronar-arterieatherosklerose ved anvendelse av pravastatin

Country Status (13)

Country Link
EP (1) EP0671170A1 (no)
JP (1) JPH07258079A (no)
KR (1) KR950031063A (no)
CN (1) CN1118688A (no)
AU (1) AU697579B2 (no)
CA (1) CA2143462A1 (no)
CZ (1) CZ56695A3 (no)
HU (1) HUT73628A (no)
IL (1) IL112639A0 (no)
NO (1) NO950930L (no)
RU (1) RU2145220C1 (no)
SG (1) SG45268A1 (no)
ZA (1) ZA951662B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2136233C (en) 1992-05-19 2004-03-30 Graham Edmund Kelly Health supplements containing phyto-oestrogens, analogues or metabolites thereof
AUPO203996A0 (en) 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
US6180660B1 (en) * 1997-08-26 2001-01-30 Merck & Co., Inc. Cholesterol-lowering therapy
EP1024696A4 (en) * 1997-10-22 2004-07-14 Merck & Co Inc COMBINATION THERAPY TO REDUCE THE RISKS ASSOCIATED WITH CARDIO AND CERBROVASCULAR DISEASES
AU754767B2 (en) * 1998-06-24 2002-11-21 Merck & Co., Inc. Compositions and methods for treating elevated blood cholesterol
CN1328369C (zh) * 1999-02-03 2007-07-25 药物研究所有限公司 培养物
DK1216038T3 (da) 1999-08-30 2005-12-27 Sanofi Aventis Deutschland Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser
AUPQ266199A0 (en) 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
IL150187A0 (en) 1999-12-14 2002-12-01 Biogal Pharmaceutical Co Ltd Novel forms of pravastatin sodium
PL362244A1 (en) * 2000-09-01 2004-10-18 Sankyo Company, Limited Medicinal compositions
AUPR255401A0 (en) * 2001-01-16 2001-02-08 Novogen Research Pty Ltd Regulation of lipids and/or bone density and compositions therefor
AUPR363301A0 (en) 2001-03-08 2001-04-05 Novogen Research Pty Ltd Dimeric isoflavones
RU2205635C1 (ru) * 2002-06-18 2003-06-10 Нестерук Владимир Викторович Способ получения твердой лекарственной формы препарата на основе правастатина
US9345671B2 (en) 2003-04-28 2016-05-24 Daiichi Sankyo Company, Limited Adiponectin production enhancer
EP1618893A4 (en) 2003-04-28 2009-08-12 Sankyo Co MEANS FOR INCREASING SUGAR CAPACITY
DE202004020671U1 (de) 2003-11-24 2005-12-08 Teva Gyogyszergyar Reszvenytarsasag Pravastatin
CN104906047B (zh) * 2015-05-19 2017-12-12 南方医科大学 一种普伐他汀钠长效缓释微球的制备方法

Also Published As

Publication number Publication date
RU2145220C1 (ru) 2000-02-10
EP0671170A1 (en) 1995-09-13
IL112639A0 (en) 1995-05-26
AU697579B2 (en) 1998-10-08
HU9500711D0 (en) 1995-04-28
AU1479395A (en) 1995-09-21
ZA951662B (en) 1996-08-28
KR950031063A (ko) 1995-12-18
SG45268A1 (en) 1998-01-16
JPH07258079A (ja) 1995-10-09
CN1118688A (zh) 1996-03-20
CA2143462A1 (en) 1995-09-12
NO950930L (no) 1995-09-12
RU95103436A (ru) 1997-01-20
CZ56695A3 (en) 1995-11-15
HUT73628A (en) 1996-08-28

Similar Documents

Publication Publication Date Title
NO950930D0 (no) Fremgangsmåte for å forsinke progresjon av koronararterie-atherosklerose ved anvendelse av pravastatin
NO985591D0 (no) FremgangsmÕte ved uttak av absorberende gjenstander
NO953043D0 (no) Fremgangsmåte for syntetisere acetotriglyceridfett
NO930690L (no) Fremgangsmaate ved separasjon av ilmenitt
NO961722D0 (no) Fremgangsmåte for karbonylering av alkylalkoholer og/eller reaktive derivater derav
FI964874A0 (fi) Vihannesten käsittely
NO974500L (no) Blandinger og fremgangsmåter for inhibering av trombogenese
NO982358L (no) FremgangsmÕte ved rensing av tekstilstoff
EP0799082A4 (en) PROCESS FOR HYDROISOMERIZATION OF WAXES
NO972022D0 (no) Fremgangsmåte ved fremstilling av papir
AU4518897A (en) Method of treating atherosclerosis
NO984914D0 (no) FremgangsmÕte ved preparering av forbedrede ferdig stekte pommes frites
NO976158D0 (no) Azetidinon-derivater for behandling av atherosklerose
NO179459C (no) Fremgangsmåte ved raffinering av papirmasse
NO975580D0 (no) Fremgangsmåte for å inhibere melanom
NO962940D0 (no) Fremgangsmåte ved hydroisomerisering
NO305146B1 (no) FremgangsmÕte ved forbedring av seismiske seksjoner
NO984145D0 (no) Fremgangsmåte ved behandling av kakao
NO20001414D0 (no) Fremgangsmåte ved opprenskning av antitrombin III
ID18513A (id) Metode pelepasan nota-nota dari produk-produk coklat
NO982503D0 (no) FremgangsmÕte ved fremstilling av dioksoazabicykloheksaner
FI955151A7 (fi) Menetelmä puumassan monivaiheista valkaisua varten
NO305346B1 (no) FremgangsmÕte ved rensing av hydrokarboner
NO942651D0 (no) Fremgangsmåte for bleking av papirmasse
KR970000258U (ko) 오디오 장식장의 코너 지지구

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application